Automated Chest Physiotherapy to Improve Outcomes in Neuro (ACTION-ICP)
Following current standard-of-care, subjects data (brain pressure) will be recorded for 1 hour and include 10-minutes of data during which the subject recieves chest physiotherapy (CPT). The hypothesis is that CPT is not harmful to brain pressure.
|Study Design:||Observational Model: Case-Crossover
Time Perspective: Prospective
|Official Title:||Automated Chest Physiotherap to Improve Outcomes in Neurocritical Care: An Intracranial Pressure Study|
- Intracranial pressure [ Time Frame: 1 hour ] [ Designated as safety issue: Yes ]
|Study Start Date:||September 2007|
|Study Completion Date:||March 2008|
|Primary Completion Date:||March 2008 (Final data collection date for primary outcome measure)|
All subjects act as their own contral
Other: Chest Physiotherapy
10-minutes of chest physiotherapy using programmed parameters that are components of the specialty beds used in ICU
The purpose of this study is to examine the effect of chest physiotherapy (CPT) on intracranial pressure (ICP). Because CPT is a normal part of the routine care provided to patients in the neurocritical care unit (NCU) this is an observational study of current practice.
- The purpose of this study is to examine the effect of chest physiotherapy (CPT) on intracranial pressure (ICP). Because CPT is a normal part of the routine care provided to patients in the neurocritical care unit (NCU) this is an observational study of current practice.
- The study will include only patients who currently have intracranial pressure monitoring devices in place (intraventricular and intraparenchymal). The study will last 1-hour and all subjects in the study will receive 10-minutes of CPT. The 10-minute CPT episode will be randomly assigned to occur 10, 20, 30 or 40-minutes into the study.
- ANCOVA using SAS will be used to explore for within and between group differences in ICP. This study observes current standard practice, there are no additional risks to the subject.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00571623
|United States, California|
|Mission Viejo, California, United States, 92691|
|United States, North Carolina|
|Durham, North Carolina, United States, 27705|
|Raleigh, North Carolina, United States, 27610|
|Principal Investigator:||DaiWai M Olson, Phd RN CCRN||Duke University|